Topics Covered History of cell-substrate DNA in biological products Methods used to quantify DNA Perceived safety issues associated with DNA Review of.
Fda 2005-dna-in-vaccines
2013 Merck Millipore Best Practices in Nucleic Acid Removal from Vaccine Processes Nov.2013
Issues Associated With Residual Cell-Substrate DNA Keith Peden Division of Viral Products Office of Vaccines Research and Review CBER, FDA Vaccines and.
